Repurposing Platinum(IV) Prodrugs to Modulate Mitochondrial Metabolism

Emmanouil Zacharioudakis, Raphaël Rodriguez

Research output: Contribution to journalArticlepeer-review

Abstract

Platinum(IV) prodrug overcomes acquired resistance to cisplatin in prostate cancer by inhibiting fatty acid oxidation.

Original languageEnglish (US)
Pages (from-to)1257-1259
Number of pages3
JournalACS Central Science
Volume9
Issue number7
DOIs
StatePublished - Jul 26 2023

ASJC Scopus subject areas

  • General Chemistry
  • General Chemical Engineering

Fingerprint

Dive into the research topics of 'Repurposing Platinum(IV) Prodrugs to Modulate Mitochondrial Metabolism'. Together they form a unique fingerprint.

Cite this